News

The value and benefits of biosimilars are increasingly becoming more apparent. Here are four areas where they are growing the most.

Despite concerns about a new opioid that is reportedly 1,000 times more powerful than morphine, FDA recently approved the new painkiller.

Certain groups expressed “deep concern” over FDA allowing an OTC asthma inhaler to be sold again after it was removed from the market 7 years ago. Here’s why.

It’s the hot new skill showing up across the resumes and job postings-but what does if have to do with healthcare?

This comprehensive, pay-for-performance approach drives clinical quality and affordability.

Here is the one surprising thing that improves patients’ ability to effectively manage their own health.

Biosimilar agents can help healthcare organizations offer patients more options for their care. So, what’s stopping payers from immediately adding them to their formularies?

As healthcare organizations move toward value-based models of reimbursement, high drug prices can sometimes get in the way of optimal care. Here are three ways that biosimilars may help.

A new cost analysis study presented at Psych Congress 2018, highlights the substantial economic burden among U.S. veterans with treatment-resistant depression and what can be done about it.

Four things you need to know about the Trump Administration’s proposed regs.

The much-anticipated 2018 midterm elections are over, but the effects on healthcare are lasting. What’s next?

Why the top PBMs are so excited about the promise of a new standardized transaction.

As drug costs continue to increase at an unsustainable rate, some hospitals are finding new solutions.

FDA approves the first new flu drug in 20 years. Here’s what’s different about it.

More affordable, more collaborative, and more personalized care is our cancer care challenge. Here’s how we get there.

As President Trump intensifies his battle with German Chancellor Angela Merkel over trade and NATO policies, he should pause to consider the lessons from another German Chancellor-Otto von Bismarck.

A pharma maker is voluntarily recalling several lots of a major heart medication. Here’s why.

As Amazon’s PillPack acquisition threatens pharmacies, CVS Health snaps back with its membership program, CarePass. Here’s how experts say it will affect managed care.

Mobile technologies offer opportunities to engage members, improve chronic care management, and prevent avoidable hospital admissions and readmissions.

Results of 20-year cohort study reveal that women with history of this serious medical illness are more vulnerable to lupus.

It can be tricky for individuals with this condition to effectively tackle their diabetes. Here’s how healthcare executives can help.

Patients must first get over these hurdles to achieve healthy outcomes. Here's how you can help.

Preventable hospital readmissions, an objective measure of quality, have long been a concern for health plans. Here’s a care plan that could be the solution.

FDA recently stopped importation and sent warning letters to numerous online sellers of illegal opioids, oncology drugs and other medicines.

Pharmacy benefit managers, cardiologists, and others praised a pharma maker for significantly reducing the price of its high cholesterol drug.

Early results from a first-of-its-kind study suggests that typical use of a fertility app is effective for avoiding an unplanned pregnancy. Payment mechanisms will need to be considered by payers.

Good leaders don’t just rely on one managerial style-they get the best out of every team member by meeting their needs.

A survey from Vizient identifies top strategies for the treatment of pain.

Healthcare stakeholders can impact a patient’s health by leveraging available capabilities and resources to help achieve better health outcomes and address this opioid epidemic.

It can be challenging for patients with schizophrenia to keep to a medication regimen-here are the reasons why it’s important to invest in strategies to help them stay compliant.